Literature DB >> 12084289

Antenatal diagnosis and treatment of congenital adrenal hyperplasia.

M I New1.   

Abstract

Congenital adrenal hyperplasia (CAH) is a family of monogenic autosomal recessive disorders of steroidogenesis in which enzymatic defects result in impaired synthesis of cortisol by the adrenal cortex. The adrenal 21-hydroxylase (21-OH) enzyme is one of five enzymes necessary for the synthesis of cortisol from cholesterol, and its deficiency is the most common enzymatic defect causing CAH. 21-OH deficiency (21-OHD) occurs in a classical form that can cause genital ambiguity at birth in genetic females. Newborn males have normal genitalia. Prenatal treatment of 21-hydroxylase deficiency with dexamethasone has been used for approximately 15 years. An algorithm was developed for prenatal diagnosis and treatment.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 12084289     DOI: 10.1007/s11934-001-0020-1

Source DB:  PubMed          Journal:  Curr Urol Rep        ISSN: 1527-2737            Impact factor:   2.862


  33 in total

1.  Prenatal treatment in congenital adrenal hyperplasia due to 21-hydroxylase deficiency: up-date 88 of the French multicentric study.

Authors:  M G Forest; H Bétuel; M David
Journal:  Endocr Res       Date:  1989       Impact factor: 1.720

2.  High frequency of congenital adrenal hyperplasia (classic 11 beta-hydroxylase deficiency) among Jews from Morocco.

Authors:  A Rösler; E Leiberman; T Cohen
Journal:  Am J Med Genet       Date:  1992-04-01

3.  High frequency of nonclassical steroid 21-hydroxylase deficiency.

Authors:  P W Speiser; B Dupont; P Rubinstein; A Piazza; A Kastelan; M I New
Journal:  Am J Hum Genet       Date:  1985-07       Impact factor: 11.025

4.  CYP11B1 mutations causing congenital adrenal hyperplasia due to 11 beta-hydroxylase deficiency.

Authors:  S Geley; K Kapelari; K Jöhrer; M Peter; J Glatzl; H Vierhapper; S Schwarz; A Helmberg; W G Sippell; P C White; R Kofler
Journal:  J Clin Endocrinol Metab       Date:  1996-08       Impact factor: 5.958

Review 5.  Congenital adrenal hyperplasia: update on prenatal diagnosis and treatment.

Authors:  A D Carlson; J S Obeid; N Kanellopoulou; R C Wilson; M I New
Journal:  J Steroid Biochem Mol Biol       Date:  1999 Apr-Jun       Impact factor: 4.292

6.  Characterization of frequent deletions causing steroid 21-hydroxylase deficiency.

Authors:  P C White; A Vitek; B Dupont; M I New
Journal:  Proc Natl Acad Sci U S A       Date:  1988-06       Impact factor: 11.205

7.  The structural basis of the multiple forms of human complement component C4.

Authors:  K T Belt; M C Carroll; R R Porter
Journal:  Cell       Date:  1984-04       Impact factor: 41.582

8.  Mapping of steroid 21-hydroxylase genes adjacent to complement component C4 genes in HLA, the major histocompatibility complex in man.

Authors:  M C Carroll; R D Campbell; R R Porter
Journal:  Proc Natl Acad Sci U S A       Date:  1985-01       Impact factor: 11.205

9.  Complete nucleotide sequence of two steroid 21-hydroxylase genes tandemly arranged in human chromosome: a pseudogene and a genuine gene.

Authors:  Y Higashi; H Yoshioka; M Yamane; O Gotoh; Y Fujii-Kuriyama
Journal:  Proc Natl Acad Sci U S A       Date:  1986-05       Impact factor: 11.205

10.  Mutations in the CYP11B1 gene causing congenital adrenal hyperplasia and hypertension cluster in exons 6, 7, and 8.

Authors:  K M Curnow; L Slutsker; J Vitek; T Cole; P W Speiser; M I New; P C White; L Pascoe
Journal:  Proc Natl Acad Sci U S A       Date:  1993-05-15       Impact factor: 11.205

View more
  3 in total

1.  Correlation between genotype and hormonal levels in heterozygous mutation carriers and non-carriers of 21-hydroxylase deficiency.

Authors:  E Napolitano; C Manieri; F Restivo; E Composto; F Lanfranco; M Repici; B Pasini; S Einaudi; E Menegatti
Journal:  J Endocrinol Invest       Date:  2010-07-29       Impact factor: 4.256

2.  A large view of CYP21 locus among Sicilians and other populations: identification of a novel CYP21A2 variant in Sicily.

Authors:  M Niceta; M Bono; C Fabiano; F Pojero; F Niceta; P Sammarco; G Corsello; P Garofalo
Journal:  J Endocrinol Invest       Date:  2010-12-15       Impact factor: 4.256

3.  Perturbed Beta-Cell Function and Lipid Profile After Early Prenatal Dexamethasone Exposure in Individuals Without CAH.

Authors:  Lena Wallensteen; Leif Karlsson; Valeria Messina; Anna Nordenström; Svetlana Lajic
Journal:  J Clin Endocrinol Metab       Date:  2020-07-01       Impact factor: 5.958

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.